A detailed history of Groupama Asset Managment transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Groupama Asset Managment holds 71,277 shares of REGN stock, worth $50.9 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
71,277
Previous 66,629 6.98%
Holding current value
$50.9 Million
Previous $70 Billion 14.1%
% of portfolio
1.56%
Previous 0.95%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$1024.09 - $1201.76 $4.76 Million - $5.59 Million
4,648 Added 6.98%
71,277 $60.2 Billion
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $14.5 Million - $17.6 Million
16,417 Added 32.7%
66,629 $70 Billion
Q1 2024

May 14, 2024

SELL
$902.69 - $993.35 $15.5 Million - $17 Million
-17,159 Reduced 25.47%
50,212 $64.5 Billion
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $52.2 Million - $59.4 Million
67,371 New
67,371 $59.2 Billion

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Groupama Asset Managment Portfolio

Follow Groupama Asset Managment and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Groupama Asset Managment, based on Form 13F filings with the SEC.

News

Stay updated on Groupama Asset Managment with notifications on news.